- ￥1668
- abinScience
- China
- HT139010
- 2026年03月03日
- ELISA, in vivo function (can trigger BTN3A on AML blasts leading to further enhanced Vγ9Vδ2 T cell-mediated killing)
- Human
- Human
企业认证
相关产品推荐更多 >
Anetumab ravtansine (ADC) 一 抗
询价
Anti-Mouse EFNA2 Polyclonal Antibody, 抗小鼠EFNA2 Polyclonal抗体
￥1008
Anti-Human TSHR/LGR3 Antibody (3BD10), PE, 抗人TSHR/LGR3抗体 (3BD10), PE标记
询价Anti-Coxiella burnetii CBU_0109 Polyclonal Antibody, 抗Coxiella burnetii CBU_0109 多克隆抗体
￥1008
Anti-Mouse CD230 Antibody (POM6), APC, 抗小鼠CD230抗体 (POM6), APC标记
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Human
- 亚型：
IgG1, kappa
- 形态：
Liquid
- 保存条件：
0.01M PBS pH 7.4
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
1 year
- 抗原来源：
Human
- 目录编号：
HT139010
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Human
- 应用范围：
ELISA, in vivo function (can trigger BTN3A on AML blasts leading to further enhanced Vγ9Vδ2 T cell-mediated killing)
- 浓度：
1mg/mL
- 靶点：
BTN3A, Butyrophilin subfamily 3 member A1, CD277, BTN3A1
- 抗体英文名：
InVivoMAb Anti-Human BTN3A1 (20.1)
- 抗体名：
InVivoMAb Anti-Human BTN3A1 (20.1)
- 规格：
100ul
| Product name | InVivoMAb Anti-Human BTN3A1 (20.1) |
|---|---|
| Catalog No. | HT139010 |
| Host species | Human |
| Species reactivity | Human |
| Immunogen | / |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa |
| Applications | ELISA, in vivo function (can trigger BTN3A on AML blasts leading to further enhanced V纬9V未2 T cell-mediated killing) |
| Target | BTN3A, Butyrophilin subfamily 3 member A1, CD277, BTN3A1 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | < 2 EU/mg |
| Expression system | / |
| Accession | O00481, O00478, P78410 |
| Alternative Names | / |
| Clone ID | 20.1 |
| Species | / |
| Product Usage Information | / |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验CD20抗体Fab’片段，并在大肠杆菌中高效可溶性分泌表达[ 8 ] ，本研究的目的在于研究嵌合抗CD20Fab’片段的抗肿瘤活性及其作用机制。一、材料和方法1、材料MTT购自Sigma公司；Annexin-V为宝灵曼公司试剂盒；TRIZOL RNA提取试剂盒为美国Gibco公司产品；兔抗人bcl-2单克隆抗体和辣根过氧化物酶标记的羊抗兔IgG为北京中山生物技术有限公司产品，嵌合抗CD20Fab’片段为我室表达并纯化。β-actin引物（上游：5-TCATGTTTGAGACCTTCAA-3，下游
，用含有10%热灭活胎牛血清的RPMI1640培养基于5% CO2，37C条件下培养。抗CD20单克隆抗体HI47由我所免疫室提供。辣根过氧化酶标记羊抗人IgG，FITC标记的羊抗鼠IgG购于北京中山生物工程公司。2、抗CD20单克隆抗体轻、重链基因的克隆利用RT-PCR法，采用抗体通用的兼并性引物，从HI47杂交瘤细胞特异性地分别扩增抗体轻链、重链可变区基因（VL和VH）后，利用编码短肽（G4S）3的连接链DNA片段，经overlap PCR，将VH和VL基因连接构成ScFv基因（约750bp
人抗干扰素-a抗体(anti-IFN-ab)ELISA试剂盒 说明书
人抗干扰素 - a抗体 ( anti-IFN - a b )ELISA 试剂盒 ( 用于血清、血浆、细胞培养上清液和其它生物体液内 ) 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 anti-IFN- a b 单抗包被于酶标板上，标准品和样品中的 anti-IFN- a b 与单抗结合，加入生物素化的抗人anti-IFN- a b ，形成免疫复合物连接在板上，辣根
技术资料暂无技术资料 索取技术资料
